Idiopathic pulmonary fibrosis (IPF) is a progressive and usually lethal interstitial lung disease of unknown etiology characterized by aberrant activation of epithelial cells that induce the migration, proliferation and activation of fibroblasts. The resulting distinctive fibroblastic/ myofibroblastic foci are responsible for the excessive extracellular matrix (ECM) production and abnormal lung remodeling. We have recently found that matrix metalloproteinase 19 (MMP-19)-deficient (Mmp19Ϫ/Ϫ) mice develop an exaggerated bleomycin-induced lung fibrosis, but the mechanisms are unclear. In this study, we explored the effect of MMP-19 deficiency on fibroblast gene expression and cell behavior. Microarray analysis of Mmp19Ϫ/Ϫ lung fibroblasts revealed the dysregulation of several profibrotic pathways, including ECM formation, migration, proliferation, and autophagy. Functional studies confirmed these findings. Compared with wild-type mice, Mmp19Ϫ/Ϫ lung fibroblasts showed increased ␣1 (I) collagen gene and collagen protein production at baseline and after transforming growth factor-␤ treatment and increased smooth muscle-␣ actin expression (P Ͻ 0.05). Likewise, Mmp19-deficient lung fibroblasts showed a significant increase in proliferation (P Ͻ 0.01) and in transmigration and locomotion over Boyden chambers coated with type I collagen or with Matrigel (P Ͻ 0.05). These findings suggest that, in lung fibroblasts, MMP-19 has strong regulatory effects on the synthesis of key ECM components, on fibroblast to myofibroblast differentiation, and in migration and proliferation. lung fibrosis; matrix metalloproteinase; fibroblasts; collagen IDIOPATHIC PULMONARY FIBROSIS (IPF) is a progressive and usually lethal lung disease of unknown etiology and without current effective therapy (15). It is characterized by injury and aberrant activation of the alveolar epithelium, which induces, through the release of a variety of growth factors, cytokines, and matrix metalloproteinases (MMPs), a flow of dysregulated epithelial-fibroblast crosstalk (20). Activated epithelial cells provoke the migration, proliferation, and activation of mesenchymal cells, with the formation of fibroblast and myofibroblast foci, whereas activated myofibroblasts secrete exaggerated amounts of extracellular matrix (ECM) molecules culminating in the destruction of the lung parenchyma (5). However, the molecular mechanisms involved in IPF development and progression are uncertain. Studies in our group and others have shown that some MMPs such as MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, and MMP-13 are highly expressed in IPF, playing diverse roles in the fibrotic response; however, the exact mechanisms are not well characterized (4, 10, 11, 21, 24, 27) . Recently, we identified the overexpression of MMP-19 in the hyperplastic alveolar epithelium of IPF lungs and demonstrated that, surprisingly, mice lacking this MMP developed an exacerbated bleomycin-induced lung fibrosis (25). Perturbations of MMP-19 levels in epithelial cells in vivo and in vitro were associated with changes in prostaglandin-endoperoxide synthase 2, suggesting that the protective role of MMP-19 might be in part through the induction of this enzyme in alveolar epithelial cells. A main observation in the fibrotic lungs of the MMP-19-deficient (Mmp19Ϫ/Ϫ) mice was the extensive formation of fibroblast/myofibroblast foci although the underlying mechanisms were not explored. Importantly, these foci represent areas of active fibrogenesis that play a critical role in the progressive fibrotic response that characterizes IPF.
lung fibrosis; matrix metalloproteinase; fibroblasts; collagen IDIOPATHIC PULMONARY FIBROSIS (IPF) is a progressive and usually lethal lung disease of unknown etiology and without current effective therapy (15) . It is characterized by injury and aberrant activation of the alveolar epithelium, which induces, through the release of a variety of growth factors, cytokines, and matrix metalloproteinases (MMPs), a flow of dysregulated epithelial-fibroblast crosstalk (20) . Activated epithelial cells provoke the migration, proliferation, and activation of mesenchymal cells, with the formation of fibroblast and myofibroblast foci, whereas activated myofibroblasts secrete exaggerated amounts of extracellular matrix (ECM) molecules culminating in the destruction of the lung parenchyma (5) . However, the molecular mechanisms involved in IPF development and progression are uncertain.
Studies in our group and others have shown that some MMPs such as MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, and MMP-13 are highly expressed in IPF, playing diverse roles in the fibrotic response; however, the exact mechanisms are not well characterized (4, 10, 11, 21, 24, 27) . Recently, we identified the overexpression of MMP-19 in the hyperplastic alveolar epithelium of IPF lungs and demonstrated that, surprisingly, mice lacking this MMP developed an exacerbated bleomycin-induced lung fibrosis (25) . Perturbations of MMP-19 levels in epithelial cells in vivo and in vitro were associated with changes in prostaglandin-endoperoxide synthase 2, suggesting that the protective role of MMP-19 might be in part through the induction of this enzyme in alveolar epithelial cells. A main observation in the fibrotic lungs of the MMP-19-deficient (Mmp19Ϫ/Ϫ) mice was the extensive formation of fibroblast/myofibroblast foci although the underlying mechanisms were not explored. Importantly, these foci represent areas of active fibrogenesis that play a critical role in the progressive fibrotic response that characterizes IPF.
In the present study, we evaluated the global gene expression as well as the functional behavior of Mmp19Ϫ/Ϫ compared with Mmp19ϩ/ϩ lung fibroblasts. Microarray analysis of MMP-19-deficient fibroblasts revealed the upregulation of numerous profibrotic genes, including several collagens and other ECM components, as well as the dysregulation of functional pathways, such as migration, proliferation, and autophagy. Functional analysis corroborated that MMP-19-deficient fibroblasts have increased growth rate and migratory capacity, as well as increased collagen production and smooth muscle-␣ actin expression with decreased autophagy-related protein 4 (ATG4) expression.
MATERIALS AND METHODS
Fibroblast isolation and culture. C57BL/6/129O1 Mmp19Ϫ/Ϫ mice kindly donated by Carlos Lopez Otin were generated as previously described (13) . Primary mouse lung fibroblasts were obtained by trypsin dispersion. Briefly, lungs from Mmp19Ϫ/Ϫ and wild-type (WT) Mmp19ϩ/ϩ mice were harvested, minced, and incubated with trypsin-EDTA solution 0.5 g/l (Sigma-Aldrich, St. Louis, MO) for 20 min. Cells were grown at 37°C in 5% CO2-95% air in 25-cm 2 Falcon flasks containing Dulbecco's Modified Eagle Medium (DMEM) (Life Technologies, Gaithersburg, MD) supplemented with 10% FBS, 100 U/ml of penicillin, 100 g/ml of streptomycin, and 2.5 mg/ml of amphotericin B. Passages 4 -6 were used for all experiments. For some experiments, cells were stimulated with transforming growth factor (TGF)-␤ (5 ng/ml) for 48 h.
The Bioethics Committee at the Instituto Nacional de Enfermedades Respiratorias in Mexico DF approved the protocol.
Growth rate assay. Mice fibroblasts (n ϭ 5 from each genotype) were seeded in a 96-well plate at a cell density of 4 ϫ 10 3 cells/well and incubated at 37°C in 5% CO 2 in DMEM medium supplemented with 10% FBS. Cell growth was determined using the water-soluble tetrazolium salt (WST-1) reagent (Roche Applied Science, Mannheim, Germany) according to manufacturer's instructions. Absorbance (450 -620 nm) was measured on a plate reader, and the results are shown as growth rate increase relative to basal values (day 0). Cell growth was also analyzed by cell proliferation assay (CyQUANT; Life Technologies, Eugene, OR). Mmp19ϩ/ϩ and Mmp19Ϫ/Ϫ fibroblasts were incubated in DMEM with 2% FBS alone or in the presence of 100 ng/ml of recombinant human MMP-19 (Creative BioMart, New York, NY). The fluorescence was determined in a microplate reader with filters set to 480 nm excitation/520 nm emission, and the results are shown as cell proliferation increases relative to basal values (day 0).
Transmigration assay (chemotaxis and chemokinesis). Migration of Mmp19Ϫ/Ϫ and Mmp19ϩ/ϩ mice fibroblasts (n ϭ 6 from each genotype) was assayed as previously described using collagen-coated chambers (QCM Haptotaxis Cell Migration Assay -Collagen 1; EMD Millipore, Billerica, MA) or BD BioCoat Matrigel Invasion Chambers with an 8-mm pore size (16) . Fibroblasts (1.5 ϫ 10 5 cells) were added to the upper chamber, and the lower chamber contained 0.3 ml of medium with PDGF-BB (20 ng/ml; R&D Systems, Minneapolis, MN). The cells that migrated were analyzed 12 h after.
For determination of chemokinesis of lung fibroblasts, a checkerboard analysis was performed (7) . PDGF (10, 20 , and 50 ng/ml) were placed in the upper or/and lower compartments of collagen-coated Boyden chambers. Fibroblasts (1.5 ϫ 10 5 cells) were added to the upper chamber and assayed as above.
Quantitative real-time RT-PCR. Total RNA was extracted from lung fibroblasts using TRIzol reagent (Invitrogen Life Technologies, Grand Island, NY). Total RNA (1 g) was reverse transcribed with cDNA using a high-capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions.
TaqMan probes were for ␣1 type I collagen expression (Mm00801666_ g1), for Mmp19 (Mm01159954_g1), for nidogen 2 (Nid2; Mm00456212_m1), for integrin ␣11 (Itga11; Mm00723741_m1), for Col14a1 (Mm00805269_m1), for fibronectin type 3 domain 1 (Fndc1; Mm01297904_m1), for Mmp14 (Mm00485054_m1), and 4352930E for eukaryotic 18S rRNA that was used as endogenous control (Applied Biosystems). Time PCR amplification was performed using an i-Cycler iQ Detection System (Bio-Rad Laboratories, Hercules, CA).
Results from three different Mmp19Ϫ/Ϫ and Mmp19ϩ/ϩ mice fibroblasts are expressed as means Ϯ SD of a relative quantification of the target gene normalized to 18S rRNA. Each cDNA was quantified in triplicate using a Mastermix solution (Applied Biosystems).
Collagen synthesis. Collagen was quantified in cell-conditioned medium using the Sircol collagen assay (Biocolor, Belfast, UK) according to the manufacturer's protocol. Briefly, fibroblasts (n ϭ 3 from each genotype) were seeded in a six-well plate at a density of 3 ϫ 10 5 cells/well and incubated overnight at 37°C in 5% CO2 in DMEM medium plus 10% FBS. Afterward, cells were incubated in serum-free medium for 48 h or with TGF-␤ (3 ng/ml). The media were collected and dialyzed against deionized water in the presence of protease inhibitors (2 M N-ethylmaleimide, 100 mM phenylmethylsulfonyl fluoride, and 1 M EDTA) and 1% sodium azide. All samples were lyophilized and resuspended in 50 l of deionized water, and 30 g of protein concentration per sample was used in the assay.
Western blot. Fibroblasts from Mmp19ϩ/ϩ and Mmp19Ϫ/Ϫ mice (n ϭ 4 -5 from each genotype) were plated on T-25 culture dishes and grown at 80% confluence. Cells were then lysated with RIPA buffer (Sigma-Aldrich) following the manufacturer's instructions. Proteins (30 g) were separated on 10% SDS-polyacrylamide gels and transferred to a PVDF membrane (0.45 m; Millipore), blocked with 5% (wt/vol) nonfat dried milk in PBS, and incubated overnight with the corresponding antibody at 4°C, including anti-smooth muscle actin (SMA) (1:500; Dako, Glostrup, Denmark), anti-ATG4C (a9482; SigmaAldrich), and anti-␤-tubulin (1:500; Santa Cruz Biotechnology, Santa Cruz, CA) that was used to test equal loading. After being washed with PBS-Tween 20 0.05%, membranes were incubated with the corresponding secondary horseradish peroxidase-conjugated antibody (1:5,000; Sigma-Aldrich) for 1 h at room temperature. Bands were detected using a chemiluminescence detection system (Millipore). Images were acquired and analyzed with ChemiDoc XRS system (Bio-Rad).
Microarray 
RESULTS
We first evaluated by real-time PCR whether lung fibroblasts from WT and MMP-19-deficient mice express the gene under basal conditions. As shown in Fig. 1 , Mmp19 was expressed in WT fibroblasts, whereas, as expected, in MMP-19-deficient fibroblasts, the gene was absent. Table 1 , and the most downregulated genes (fold change Ն8) are in in Table 2 .
MMP-19-deficient fibroblasts showed a significant increase of genes associated with secreted proteins, many of them related with ECM, including fibrillar, fiber-associated, and basement membrane collagens such as Col XIV␣1, Col XXVIII␣1, Col VIII␣1, Col IV␣6, Col XI␣1, and Col I␣1. Two members of the a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family, ADAMTS-2 and -3, that are involved in procollagen processing were also upregulated. Other increased ECM genes were fibulin 5, fibulin 7, nephroblastoma overexpressed gene (Ccn3), nidogen 2, osteoglycin, podocan, and fibronectin type III domain 1.
There was a modest upregulation of Mmp14, a membranebound MMP (MT1-MMP), without increase of any other member of the MMP family, indicating that there was no compensation for the lack of MMP-19. Several myosin heavychain genes were strongly upregulated in MMP-19-deficient fibroblasts, suggesting that an increased number of them were myofibroblasts.
A network examination using IPA software showing the molecular networks altered by the absence of MMP-19 in mouse fibroblasts is illustrated in Fig. 2 .
The expression of several genes associated with proliferation and migration was increased in MMP-19-deficient lung fibroblasts ( Table 1) . As illustrated in Fig. 3 , one of the dysregulated transduction pathways leading to the change in the proliferation rate was ERK1 pathway, which in this model was specifically linked to an increase of the cytokine fibroblast growth factor 21, proliferation receptor interleukin 6, and the cytokine cardiotrophin 1. Other molecules dysregulated in MMP-19-deficient fibroblasts and associated to cellular proliferation were integrin ␣-11, insulin-like growth factor-1 (IGF1), v-Myc avian myelocytomatosis viral oncogene neuroblastomaderived homolog (MYCN), and hypoxanthine phosphoribosyltransferase 1, this latter possibly regulating glucose metabolism and nitric oxide. Several genes involved in p38 MAPK pathway and cell migration were also upregulated, including nephroblastoma overexpressed, dipeptidyl-peptidase 4, c-Fosinduced growth factor, angiopoietin 2, plasminogen activator urokinase, laminin ␣5 IGF, ezrin, and WNT1-inducible signaling pathway protein 1 (WISP1) (Fig. 4) .
We corroborated by quantitative RT-PCR the level of expression of several differentially expressed genes. As shown in Fig. 5A , Col14␣1, Itga11, Nid2, Mmp14, and Fndc1 were significantly upregulated under basal conditions in the Mmp19-deficient mice.
To examine whether the addition of recombinant MMP-19 modifies the expression of these upregulated genes, WT and MMP-19-deficient fibroblasts were incubated in serum-free medium with or without the recombinant protein (200 ng/ml per 18 h). As shown in Fig. 5B , addition of MMP-19 did not modify the expression of Col14␣1, Itga11, Nid2, Mmp14, and Fndc1 in WT fibroblasts. In contrast, in MMP-19-deficient fibroblasts, the recombinant protein significantly reduces the expression of these genes (Fig. 5C) .
Mmp19 deletion increases collagen expression. To evaluate the effects of MMP-19 deficiency on matrix production, we measured the expression and production of collagen I by quantitative RT-PCR and Sircol assay. As illustrated in Fig. 6A , under basal conditions, Mmp19Ϫ/Ϫ lung fibroblasts showed significantly higher levels of ␣1-collagen I gene expression (P Ͻ 0.001). Consistent with higher mRNA levels, increased levels of collagen protein in the cell culture supernatant were also detected (P Ͻ 0.05) (Fig. 6B) . Similar results were obtained when lung fibroblasts were stimulated with 3 ng/ml of TGF-␤.
Expression of ␣-SMA is upregulated in Mmp19Ϫ/Ϫ lung fibroblasts. Fibroblast to myofibroblast differentiation, which is often evaluated according to ␣-SMA expression, plays an important role in tissue remodeling and fibrogenesis. Therefore, we assessed whether the absence of Mmp19 gene expression has an effect on this process. Fibroblast lysate proteins derived from four different Mmp19Ϫ/Ϫ and Mmp19ϩ/ϩ mice were analyzed for ␣-SMA expression by Western blotting. As shown in Fig. 7 , MMP-19-deficient mice spontaneously expressed significantly higher amounts of ␣-SMA compared with the WT littermates (P Ͻ 0.05). After stimulation with TGF-␤1, a known inducer of myofibroblast differentiation, both Mmp19ϩ/ϩ and Mmp19Ϫ/Ϫ lung fibroblasts showed a significant increase in ␣-SMA.
MMP-19-deficient mice exhibit diminished ATG4C protein expression.
Among the downregulated genes is autophagy related 4C, cysteine peptidase (Atg4c), which participates in lipidation of LC3-I to phosphatidylethanolamine (PE) to expand the autophagosomal membrane. A decreased amount of Atg4c may provoke an impaired autophagic response.
To validate the results obtained in the microarrays, we analyzed the amount of ATG4C protein by Western blot in lung fibroblasts obtained from five different Mmp19Ϫ/Ϫ and Mmp19ϩ/ϩ mice. As illustrated in Fig. 8 , a marked decrease of Atg4c (ϳ52 kDa) was detected in the Mmp19-deficient mice. A decrease of a nonidentified ϳ30-kDa band was also observed.
Mmp19 deletion increases lung fibroblast growth rate. Because several genes implicated in cell proliferation were upregulated in Mmp19-deficient fibroblasts, cell growth was examined in the Mmp19Ϫ/Ϫ and Mmp19ϩ/ϩ cells using the WST-1 assay. As illustrated in Fig. 9 , primary lung fibroblasts from Mmp19Ϫ/Ϫ mice cultured with DMEM supplemented with 10% FBS displayed a significantly higher growth rate, as measured by WST-1 assay, compared with Mmp19ϩ/ϩ cells from the second day on; *P Ͻ 0.05 at 48 h; **P Ͻ 0.01 at 72 and 96 h. We also evaluated cell proliferation by CyQUANT assay in fibroblasts cultured in DMEM supplemented with 2% FBS in the presence or absence of MMP-19 recombinant protein (100 ng/ml). As shown in Fig. 9B , recombinant MMP-19 significantly decreased cell proliferation at 72 h in MMP-19-deficient fibroblasts, whereas it had no effect on WT fibroblasts.
Mmp19 deletion increases transmigration through ECM components.
To analyze the effects of Mmp19 deficiency on fibroblast migration, we used collagen I-or Matrigel-coated Boyden chambers. Cell migration was examined in the presence or absence of PDGF-B, a fibroblast-chemotactic mediator. As seen in Fig. 10 , fibroblast transmigration through collagen I was significantly higher in Mmp19Ϫ/Ϫ compared with Mmp19ϩ/ϩ cells either spontaneously (P Ͻ 0.01) or in response to PDGF-B (P Ͻ 0.01). Similar results were observed when transmigration was examined using Matrigel both under basal conditions and with PDGF.
To examine whether PDGF also has chemokinetic properties, checkerboard was performed. As illustrated in Fig. 11 , PDGF showed both chemotactic (11A) and chemokinetic (11B) activities although its effect was higher in MMP-19-deficient fibroblasts. 
DISCUSSION
IPF is a progressive and lethal disease, characterized by epithelial cell dysfunction resulting in the increase of the fibroblast/myofibroblast population and the excessive accumulation of ECM, mainly fibrillar collagens. The abnormal remodeled matrix may lead to a positive feedback of mesenchymal cell activation and progressive fibrosis. In these biopathological processes, a variety of mediators, including several MMPs contributes to the pathogenesis of IPF, but their specific roles are not fully understood (5) .
We recently demonstrated that MMP-19, an MMP that shows some unique structural features, expression pattern, and functional characteristics (14) , is increased in alveolar epithelial cells adjacent to fibrotic regions of IPF lungs. Interestingly, we found that the MMP-19-deficient mice displayed a more severe bleomycin-induced fibrotic lung disorder, suggesting that this enzyme may have a protective antifibrogenic role (25) . Supporting this notion, we also observed that MMP-19 induces in alveolar epithelial cells the expression of cyclooxygenase-2 the enzyme responsible for the synthesis of the prostaglandin E 2 , a potent antifibrotic mediator. An important observation in the fibrotic response in the MMP-19-deficient mice was the remarkable increase of fibroblasts/myofibroblasts that formed typical foci in the lungs. However, the role of MMP-19 in mesenchymal cells was not explored.
In the present study, we evaluated the influence of MMP-19 deficiency in a number of fibroblast functions relevant for fibrogenesis. We first examined the gene expression profiles of MMP-19-deficient and MMP-19-sufficient lung fibroblasts through microarray analysis. Our results revealed that several genes and pathways involved in relevant fibrogenic activities, such as proliferation, migration, collagens synthesis, cell-matrix interaction, and autophagy, were dysregulated in MMP-19-deficient fibroblasts, conferring them a profibrotic phenotype. Migration and proliferation are two essential mechanisms for the clustering of fibroblasts in damaged tissues during the fibrotic response, and several growth factors that participate in these processes were strongly dysregulated in MMP-19-deficient mice. For example, the ␣11 integrin (ITGA11), a major collagen receptor involved in collagen reorganization, was one of the most upregulated genes. Importantly, this integrin induces cell proliferation regulating the expression of members of the IGF family, and one of them, IGF1, a multifunctional regulator of cell proliferation, survival, and differentiation in multiple cell types, was also upregulated in the MMP-19-deficient fibroblasts (26) . IGF1 overexpression has been associated with increased fibrogenesis in some experimental models (22) . Furthermore, recent work demonstrated that ITGA11 is induced by TGF-␤1 contributing to the differentiation of fibroblasts to myofibroblasts, a process that was also revealed in our study, where MMP-19-deficient fibroblasts showed higher levels of ␣-SMA, a major characteristic of myofibroblasts (9, 23) . Curiously, the protooncogene MYCN, which is dysregulated in diverse cancers, was highly upregulated in MMP-19-deficient fibroblasts. Upregulation of this gene has been noticed in the exaggerated fibroblast proliferation associated with hypertrophic scar formation (17) . The upregulation of this gene may be related to the increase of SET and MYND domain-containing protein 3, a histone methyltransferase that may activate the transcription of a set of downstream genes, including MYCN, and that also induces cell migration and proliferation (18) . On the other hand, several genes that inhibit cell proliferation were downregulated. Of note, interferoninducible protein, p200, which has a modular organization consisting of one (p203) or two (p202 and p204) 200-aminoacid motifs and displays an antiproliferative activity, was strongly downregulated (3). Another interesting downregulated gene was the histone methyltransferase SUV39H1, whose encoded protein trimethylates lysine 9 of histone H3, resulting in transcriptional gene silencing. Recent studies have shown that telomeres in SUV39H1 knockdown cells are longer compared with those of the control without modifications in telomerase activities but likely associated to loss of DNA methylation at subtelomeric regions (2). On the basis of these findings, we evaluated fibroblast proliferation by two assays and fibroblast chemotaxis and chemokinesis through a migration chamber assay, which confirmed that MMP-19-deficient fibroblasts have a marked increase in proliferative and migratory activities. As a proof of concept, we examined the effect of adding back MMP-19 recombinant protein on gene expression and fibroblast proliferation. Gene expression levels of Col␣1, Mmp14, Itga11, Nid2, and Fncd1 that were originally increased in MMP-19-deficient fibroblasts were significantly decreased when the recombinant was added, reaching similar levels to the WT fibroblasts. Similarly, recombinant protein decreased the exaggerated cell proliferation of MMP-19-deficient fibroblasts. These results indicate that the observed differences in fibroblast behavior are specifically related to MMP-19 gene modification.
Scar deposition resulting from an altered wound-healing response is characterized by increased production of matrix proteins, mainly fibrillar collagens. In this context, several collagens, including collagen type I, the prototype of increased fibrillar collagens in fibrosis, were upregulated in MMP-19-deficient fibroblasts. The increase of the ␣1 type I collagen was corroborated by quantitative RT-PCR and the increase of secreted collagens by the Sircol assay, a dye-binding method for the analysis of soluble collagens. In addition, several genes that increase collagen synthesis were upregulated in the MMP-19-deficient fibroblasts, including WISP1. It has been shown that stimulation of mouse and human lung fibroblasts with recombinant WISP1 enhanced the production of ECM components, primarily type I collagen and fibronectin (6); both molecules increased in MMP-19-deficient fibroblasts. Network analysis showed that expression of collagens and MMP-14, the only "compensatory" upregulated MMP, was likely associated to ERK activation.
Another interesting upregulated gene was Loxl1, a member of the lysyl oxidase gene family, which are all ECM-embedded copper-dependent amine oxidases that play critical roles in the formation of crosslinks in collagens and elastin and which are usually highly expressed in fibrotic processes (8) . The increased expression of fibrillar and fiber-associated collagens and a member of the Lox family confirms the profibrotic phenotype of the MMP-19-deficient fibroblasts.
Autophagy is a fundamental cell process that involves the sequestration of cytoplasmic components in double-membraned autophagosomes that fuse with lysosomes, where their cargoes are delivered for degradation and recycling. Alterations in autophagy have been implicated in several chronicdegenerative processes, and recent data indicate that it is decreased in IPF lungs and fibroblasts (1, 12, 19) . In the initial steps of autophagy, the proteolytic processing of ATG8, by the cysteine protease ATG4, is critical for conjugation of ATG8 with phosphatidylethanolamine and, subsequently, autophagosome formation. We found by gene expression and protein analysis a marked decrease of ATG4, suggesting that lack of MMP-19 may cause alterations in the autophagy-lysosomal pathway. The effect of autophagic inhibition on fibroblasts in the context of a fibrotic response is presently unclear, but, interestingly, it may lead to increased ␣-SMA, fibronectin, and collagen expression (12), as we found in our microarray data, and to increased ECM accumulation because of decreased intracellular degradation.
In summary, our findings demonstrate that MMP-19 has strong regulatory effects on fibroblast migration and proliferation as well as the fibroblast to myofibroblast differentiation and the synthesis of key ECM components. These effects on fibroblast behavior may represent a promising therapeutic approach in fibrotic disorders.
